Blood cancer marker could help identify patients at high risk

Australian researchers have found a new biomarker for multiple myeloma that could help doctors rapidly identify patients at greatest risk of poor outcomes, enabling more personalized and effective treatments. Multiple myeloma is an incurable cancer of plasma cells in the bone marrow and is the second most common blood cancer worldwide, with more than 188,000 new cases diagnosed each year.

Raccontata damedicalxpress.com